Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Dosage Forms × Genitourinary × Clear all

Phase

Phase NA 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 2 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

pembrolizumab 78 Nivolumab 55 Docetaxel 51 Cyclophosphamide 42 enzalutamide 37 Magnetic Resonance Spectroscopy 30 Ipilimumab 30 Gemcitabine 26 fludarabine 24 Everolimus 24 Prednisone 23 Abiraterone Acetate 23 Radiotherapy 22 Paclitaxel 22 Cisplatin 20 Specimen Handling 19 cabozantinib 18 Sunitinib 18 Carboplatin 18 pazopanib 17 Radiosurgery 17 atezolizumab 16 bicalutamide 15 Sorafenib 15 Biopsy 15 Bevacizumab 15 apalutamide 13 abiraterone 13 Radiation 13 temsirolimus 12

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01784757 2021-03-17

ARAFOR

Orion Corporation, Orion Pharma

Phase 1 Completed

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡